IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
6.90
-0.15 (-2.13%)
Dec 20, 2024, 4:00 PM EST - Market closed
IGM Biosciences Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for IGM Biosciences stock have an average target of 17.43, with a low estimate of 9.00 and a high estimate of 27. The average target predicts an increase of 152.61% from the current stock price of 6.90.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IGMS stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 5 | 4 | 4 | 4 | 4 | 2 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Initiates $21 | Buy | Initiates | $21 | +204.35% | Dec 6, 2024 |
| Stifel | Stifel | Strong Buy Maintains $25 → $27 | Strong Buy | Maintains | $25 → $27 | +291.30% | Nov 11, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $20 | Buy | Maintains | $17 → $20 | +189.86% | Oct 18, 2024 |
| Wedbush | Wedbush | Buy Maintains $25 → $22 | Buy | Maintains | $25 → $22 | +218.84% | Oct 1, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $20 → $17 | Buy | Maintains | $20 → $17 | +146.38% | Oct 1, 2024 |
Financial Forecast
Revenue This Year
10.37M
from 2.13M
Increased by 386.95%
Revenue Next Year
6.87M
from 10.37M
Decreased by -33.74%
EPS This Year
-3.35
from -4.71
EPS Next Year
-2.23
from -3.35
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 66.7M | 24.8M | 43.8M | |||
| Avg | 10.4M | 6.9M | 12.9M | |||
| Low | 2.2M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 3,030.3% | 139.4% | 537.9% | |||
| Avg | 386.9% | -33.7% | 87.4% | |||
| Low | 4.3% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.77 | -1.52 | -1.35 | |||
| Avg | -3.35 | -2.23 | -1.94 | |||
| Low | -3.59 | -3.90 | -3.22 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.